N2 is not N2 is not N2

被引：0
|
作者：
Hanna, Wael C. [1 ]
机构：
[1] McMaster Univ, Dept Thorac Surg, Hamilton, ON L8N 4A6, Canada
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2015年 / 150卷 / 06期
关键词：
RANDOMIZED CONTROLLED-TRIAL; CELL LUNG-CANCER; CHEMOTHERAPY; RADIOTHERAPY; RESECTION;
D O I：
10.1016/j.jtcvs.2015.06.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1494 / 1495
页数：2
相关论文
共 50 条
  • [21] Persistent N2 After Induction Is Not a Contraindication to Surgery for Lung Cancer
    Andrews, Weston G.
    Louie, Brian E.
    Castiglioni, Massimo
    Dhamija, Ankit
    Farivar, Alex S.
    Chansky, Joshua
    White, Peter T.
    Aye, Ralph W.
    Vallieres, Eric
    Bograd, Adam J.
    ANNALS OF THORACIC SURGERY, 2022, 114 (02): : 394 - 400
  • [22] Laparoscopic surgery in patients diagnosed with clinical N2 colon cancer
    Numata, Masakatsu
    Sawazaki, Sho
    Aoyama, Toru
    Tamagawa, Hiroshi
    Godai, Teni
    Sato, Tsutomu
    Saeki, Hiroyuki
    Saigusa, Yusuke
    Taguri, Masataka
    Mushiake, Hiroyuki
    Oshima, Takashi
    Yukawa, Norio
    Shiozawa, Manabu
    Masuda, Munetaka
    Rino, Yasushi
    SURGERY TODAY, 2019, 49 (06) : 507 - 512
  • [23] Single Station N2 NSCLC: A Brief Reflection on Possible Overdoing
    Cafarotti, Stefano
    Cesario, Alfredo
    Cusumano, Giacomo
    Granone, Pierluigi
    ANNALS OF THORACIC SURGERY, 2009, 88 (06): : 2069 - 2070
  • [24] The Importance of Mediastinal Down-Staging During Induction Therapy of N2 Disease
    De Leyn, Paul
    Decaluwe, Herbert
    Dooms, Christophe
    Vansteenkiste, Johan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S71 - S72
  • [25] Surgical Resection of Non-Small Cell Lung Cancer with N2 Disease
    Donington, Jessica S.
    Pass, Harvey I.
    THORACIC SURGERY CLINICS, 2014, 24 (04) : 449 - +
  • [26] POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes
    Tanner, Nichole T.
    Silvestri, Gerard A.
    CHEST, 2015, 148 (06) : 1373 - 1375
  • [27] Splitting hairs or not: importance of N2 subclassification after neoadjuvant treatment and surgery COMMENT
    Chan, Joyce W. Y.
    Lau, Rainbow W. H.
    Ng, Calvin S. H.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 61 (02) : 277 - 278
  • [28] Predictors for the efficacy of Endostar combined with neoadjuvant chemotherapy for stage IIIA (N2) NSCLC
    Zhao, Xiaoliang
    Wen, Xiaohua
    Wei, Wei
    Su, Yanjun
    You, Jian
    Gong, Liqun
    Zhang, Zhenfa
    Wang, Meng
    Xiao, Jianyu
    Wei, Xiyin
    Wang, Changli
    CANCER BIOMARKERS, 2018, 21 (01) : 169 - 177
  • [29] Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?
    Pages, P. -B.
    Pforr, A.
    Delpy, J. -P.
    Abou Hanna, H.
    Bernard, A.
    REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (05) : 485 - 492
  • [30] Surgically Managed Clinical Stage IIIA-Clinical N2 Lung Cancer in The Society of Thoracic Surgeons Database
    Boffa, Daniel
    Fernandez, Felix G.
    Kim, Sunghee
    Kosinski, Andrzej
    Onaitis, Mark W.
    Cowper, Patricia
    Jacobs, Jeffrey P.
    Wright, Cameron D.
    Putnam, Joe B.
    Furnary, Anthony P.
    ANNALS OF THORACIC SURGERY, 2017, 104 (02): : 395 - 403
12345